GSK extend evaluation of FibroSelect purification technology

London, UK – 5 December 2016 – Puridify Limited (“Puridify”), developers of novel bioprocessing purification technologies for industrial biomolecule manufacture, today announced the signing of an 18 month collaboration with GlaxoSmithKline (“GSK”) to extend the evaluation of Puridify’s FibroSelect purification technology with a view to building a package to support potential use of nanofibres in toxicology and clinical manufacture. Read more…

Puridify wins prestigious bioprocess industry award

London, UK – 21 October 2016 – Puridify Limited (“Puridify”), a developer of novel bioprocessing purification technologies for industrial biomolecule manufacture, has won a 2016 BioProcess International Award for best collaboration with GlaxoSmithKline to advance industrial evaluation of Puridify’s FibroSelect. Read more…

Puridify named as finalist for two prestigious bioprocess industry awards at BPI

London, UK – 30 September 2016 – Puridify Limited (“Puridify”), developers of novel bioprocessing purification technologies for industrial biomolecule manufacture, has been announced as a finalist for two BioProcess International Awards. These prestigious industry awards recognize the outstanding people, organizations, and technologies that define excellence and that have changed the status-quo by enabling more effective, less expensive biotherapeutic development and …

Mar 2016: Puridify establishes Scientific Advisory Board

London, UK – 07 March 2016 – Puridify Limited (“Puridify”), developers of novel bioprocessing purification technologies for industrial biomolecule manufacture, today announced the establishment of a Scientific Advisory Board (SAB). The SAB comprises world-renowned key opinion leaders in the field of biotherapeutic manufacturing, with a wealth of experience covering both the academic and industrial setting. The SAB comprises the following members:

Jan 2016: Puridify awarded Industrial Biotechnology Catalyst project

Puridify was successful in leading this application for a £1,757,129 Industrial Research project from Innovate UK’s Industrial Biotechnology Catalyst program. This will see Puridify and University College London build on existing collaborations and feasibility data to develop new purification tools and strategies that can be applied across a range of next generation biotherapeutics to enable their cost effective manufacture delivering novel therapies …

Oct 2015: Puridify completes Series A funding for commercialisation of single-use nanofibre-based purification technology

Platform technology set to transform purification in bioprocess manufacturing London, UK – 21 October 2015 – Puridify Limited (“Puridify”), developers of novel bioprocessing purification technologies for industrial biomolecule manufacture, today announced the closing of a £2.2 million Series A funding round. This follow-on investment by existing investors Imperial Innovations, SR One and UCL Business, brings the total raised including grant …

March 2015: Puridify awarded Industrial Biotechnology Catalyst project

Puridify was successful leading this application for a £2,354,840 Industrial Research project from Innovate UK’s Industrial Biotechnology Catalyst program. This will see Puridify and University College London carry out the industrial validation of the nanofibre platform technology for biotherapeutic manufacture driving forward the technology’s commercialisation. This work is co-funded by the Engineering and Physical Sciences Research Council (EPSRC) and the Biotechnology …

May 2014: Imperial Innovations and SR One lead £850,000 seed financing for Puridify

Imperial Innovations Group plc (AIM:IVO, ‘Innovations’), the leading technology commercialisation and investment company and S.R.One Ltd, GlaxoSmithKline’s venture capital fund, announce today that they have led, alongside co-investor UCL Business PLC (UCLB), an £850,000 seed financing for Puridify, a newly formed company providing purification solutions for biotherapeutic manufacturing.

April 2014: Puridify’s successful Collaborative R&D award program application

Puridify was successful leading this application for a £499,728 Technology-inspired innovation – Biosciences project from the Technology Strategy Board’s Collaborative R&D award program. This will see Puridify and University College London develop and test its platform technology with a series of scale down prototypes with key end users driving forward the technology’s commercialisation. This work is co-funded by the Biotechnology …